Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04031989 · ClinicalTrials.gov registry record · NA

Repository of Phase Signals for Pulmonary Hypertension Algorithm Development

A NA study of Cardiovascular Diseases and Cardiac Disease, sponsored by Analytics For Life.

Active
Registry status
NA
Development phase
2,500
Enrollment target
17
Study locations

NCT04031989: Active NA study of Cardiovascular Diseases and Cardiac Disease, sponsored by Analytics For Life.

NCT04031989 is a NA study of Cardiovascular Diseases and Cardiac Disease that is active but no longer recruiting, run by Analytics For Life. The registered enrollment target is 2,500 participants, below the 26,966-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (91% lower). The trial reports 17 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04031989, a NA study of Cardiovascular Diseases and Cardiac Disease, is active but no longer recruiting, sponsored by Analytics For Life.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
2,500 participants
Enrollment target
17
Study locations

Study Summary

This study is designed as a repository study to collect resting cardiac phase signals and subject meta data from eligible subjects using the Phase Signal Recorder (PSR) prior to Right Heart Cath (RHC). The repository data will be used for the purposes of research, development, optimization and testing of machine-learning algorithms developed by CorVista Health (formerly Analytics 4 Life).

Interventions

  • DEVICE CorVista Capture

Study Locations (17)

North Carolina

  • Duke University - Durham
  • LeBauer Cardiovascular Research Foundation - Greensboro
  • New Hanover Regional Medical Center - Wilmington

South Carolina

  • AnMed Health - Anderson
  • Medical University of South Carolina - Charleston
  • Lexington Cardiology / Lexington Medical Heart and Vascular Center - Lexington

Colorado

  • UC-MHS (UCHealth Memorial) - Colorado Springs
  • University of Colorado-MHS (UCHealth Memorial) - Colorado Springs

Pennsylvania

  • Allegheny Health Network Research Institute - Natrona Heights
  • Allegheny Health Network Research Institute - Pittsburgh

Georgia

  • WellStar Research Institute - Marietta

Illinois

  • Loyola University Chicago - Maywood

Mississippi

  • Cardiology Associates Research, LLC - Tupelo

Nebraska

  • Bryan Heart - Lincoln

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2019-04-15
Est. Completion 2024-08-31
Phase NA
Analytics For Life

1 total trials

What the registry record for NCT04031989 still lists

NCT04031989 is an interventional study that assigns participants to a tested intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, below the 26,966-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (91% lower).

The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which CorVista Capture is the first listed.

NCT04031989 lists 17 locations in 11 states (North Carolina, South Carolina, Colorado).

Frequently Asked Questions

What is clinical trial NCT04031989 about?

NCT04031989 is a clinical study titled "Repository of Phase Signals for Pulmonary Hypertension Algorithm Development". This study is designed as a repository study to collect resting cardiac phase signals and subject meta data from eligible subjects using the Phase Signal Recorder (PSR) prior to Right Heart Cath (RHC). The repository data will be used for the purposes of research, development, optimization and testi...

What is the current status of trial NCT04031989?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 2,500 participants. The study started on 2019-04-15. Estimated completion is 2024-08-31.

What conditions does trial NCT04031989 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Cardiac Disease, Right Heart Failure.

What interventions are being tested in trial NCT04031989?

The interventions under investigation include: CorVista Capture (DEVICE).

Who is sponsoring clinical trial NCT04031989?

This trial is sponsored by Analytics For Life, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04031989 being conducted?

This trial has 17 study locations across Colorado, Georgia, Illinois, Mississippi, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04031989's enrollment target sits among peer trials

2,500 33rd of 300 higher than 268 of 300 other Cardiovascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001160 · 2,500 participants

    Studies on Tumors of the Thyroid

  • NCT01904188 · 2,500 participants

    Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

  • NCT02257229 · 2,500 participants

    Prospective Evaluation of Treatment for Clubfoot

  • NCT02530658 · 2,500 participants

    Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04031989, the US trial registry maintained by the National Library of Medicine. NCT04031989 (large enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.